What have we learned about degradomers? See how our team is elevating the science, from exploring gene therapy to degrading specific tissues.
See how the AbbVie-Calico Life Sciences collaboration turns the traditional partnership upside down to tackle age-related diseases.
Our 2022 priorities build on our commitment to valuing differences and enhancing an inclusive culture.
From neuroscience to ophthalmology to bioengineering, see how our head of aesthetic science follows his passions to bring new opportunities to patients.
The ongoing search for an answer sparked this doctor’s decades-long career in neurodegenerative disease research.
In the birthplace of biotech, we’re continuing our investment in innovation. 
With the most complete human genome sequenced yet, AbbVie’s Genomics Research Center aims to find out.
Leaders have made learning a part of the culture and empower employees to take charge of their development
Our head of global medical affairs lives for solving beautiful problems. See how this curious leader connects science to real patients’ needs.
From river blindness to malaria, pro bono research and public-private partnerships create an impact on global public health.